Beta blockers, used for decades after heart attacks, provide no benefit for patients with preserved heart function, according to the REBOOT trial. The massive study also found women faced higher risks when taking the drug. Experts say the results will change heart treatment guidelines worldwide.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- This common vaccine cuts heart risk nearly in half in new study
- The surprising cancer link between cats and humans
- He survived 48 hours without lungs and lived
- DNA origami vaccines could be the next leap beyond mRNA
- Scientists inject one tumor and watch cancer vanish across the body
- A lab mistake at Cambridge reveals a powerful new way to modify drug molecules
- Severe COVID or flu may raise lung cancer risk years later
- Parents’ stress may be quietly driving childhood obesity, Yale study finds
- Golden Retriever genes linked to anxiety, aggression, and intelligence in humans
- A bold new plan could finally cure type 1 diabetes
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
